| Literature DB >> 29715276 |
Jee-Hyun Jung1,2, Young-Sun Moon1, Bo-Mi Kim3, Young-Mi Lee4, Moonkoo Kim1,2, Jae-Sung Rhee5,6.
Abstract
Flounder is a promising model species for environmental monitoring of coastal regions. To assess the usefulness of liver transcriptome profiling, juvenile olive flounder Paralichthys olivaceus were exposed to two pollutants, bisphenol S (BPS) and benzo[a]pyrene (BaP), which have different chemical characteristics and have distinct modes of metabolic action in teleost. Six hours after intraperitoneal injection with BPS (50 mg/kg bw) or BaP (20 mg/kg bw), liver transcriptomes were analyzed using the Illumina Hiseq 3000 platform. Interestingly, the transcriptome was highly sensitive and was distinctively expressed in response to each chemical. The primary effect of BPS was significantly increased transcription of egg process and vitellogenesis related genes, including vitellogenins (vtg1, vtg2), zona pellucida sperm-binding proteins (zp3, zp4), and estrogen receptors (erα, erβ), with increases in plasma 17β-estradiol (E2) and vitellogenin (VTG) concentrations. Following BaP treatment, detoxification- and biotransformation-related genes such as cyp1a1 and UDP-glucuronosyltransferase (ugt1a1) were significantly increased, with an increase in EROD activity. In both transcriptomes, mRNA expression of genes involved in antioxidant defense systems was increased, while genes involved in innate immunity were decreased upon BPS or BaP exposure with a decrease in complement activity. This study provides useful insight into the chemical-specific hepatic transcriptional response of P. olivaceus and suggests a basis for further studies examining biomarker application of liver transcriptomes for environmental pollution.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29715276 PMCID: PMC5929548 DOI: 10.1371/journal.pone.0196425
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Summary of the assembly statistic information.
| Sample | Merge | |
|---|---|---|
| All transcript contigs | Only longest isoform per gene | |
| Total trinity 'genes' | 99,988 | 99,988 |
| Total trinity transcripts | 124,125 | 99,988 |
| %GC | 46.67 | 46.06 |
| N90 (bp) | 335 | 282 |
| N80 | 602 | 420 |
| N70 | 1,039 | 661 |
| N60 | 1,569 | 1,072 |
| N50 | 2,110 | 1,629 |
| N40 | 2,680 | 2,237 |
| N30 | 3,341 | 2,948 |
| N20 | 4,172 | 3,827 |
| N10 | 5,543 | 5,228 |
| Maximum contig length (bp) | 17,656 | 17,656 |
| Minimum contig length (bp) | 201 | 201 |
| Median contig length (bp) | 431 | 364 |
| Average contig length (bp) | 983.63 | 789.82 |
| Total assembled bases (bp) | 122,093,418 | 78,972,560 |
Fig 1Comparison of transcriptional expression patterns of whole libraries and analysis of chemical-specifically expressed genes.
(A) Transcriptional pattern analysis of each library (i.e., two control, three BPS-exposed, and three BaP-exposed liver tissues) by employing heat map and hierarchical clustering; (B) PCA plot analysis of transcriptional profile of each library. Each sample is depicted with a different color. (C) Number of statistically significant transcripts (i.e., over 2 fold; P < 0.05) in P. olivaceus liver tissues exposed to BPS or BaP; (D) the number of uniquely or commonly up- or downregulated transcripts in the P. olivaceus liver tissues exposed to BPS or BaP. Detailed list of the commonly modulated genes is included in S5 and S6 Tables.
Fig 2Functional classification of differentially expressed genes.
Comparison of Gene Ontology (GO) in terms of (A) biological process, (B) cellular components, and (C) molecular function that were enriched in the BPS- or BaP-exposed liver tissues of P. olivaceus. Composition of each GO term is represented as a percentage. For detailed information see in S3 Table.
Most highly represented KEGG classifications in the liver transcriptomes of the olive flounder Paralichthys olivaceus upon BPS and BaP exposures.
| BPS exposure | BaP exposure | ||||
|---|---|---|---|---|---|
| Classification | Map ID | # | Classification | Map ID | # |
| Metabolic pathways | 1100 | 77 | Metabolic pathways | 1100 | 129 |
| Biosynthesis of secondary metabolites | 1110 | 28 | Biosynthesis of secondary metabolites | 1110 | 39 |
| Microbial metabolism in diverse environments | 1120 | 23 | Protein processing in endoplasmic reticulum | 4141 | 34 |
| Biosynthesis of antibiotics | 1130 | 20 | Biosynthesis of antibiotics | 1130 | 28 |
| Pathways in cancer | 5200 | 15 | Pathways in cancer | 5200 | 27 |
| Carbon metabolism | 1200 | 15 | Microbial metabolism in diverse environments | 1120 | 24 |
| Protein processing in endoplasmic reticulum | 4141 | 13 | PI3K-Akt signaling pathway | 4151 | 19 |
| PI3K-Akt signaling pathway | 4151 | 13 | Carbon metabolism | 1200 | 18 |
| Non-alcoholic fatty liver disease (NAFLD) | 4932 | 12 | Epstein-Barr virus infection | 5169 | 18 |
| Human papillomavirus infection | 5165 | 12 | FoxO signaling pathway | 4068 | 16 |
Fig 3Comparison of KEGG pathways with mapped genes.
(A) “Protein procession in endoplasmic reticulum” and (B) Benzo[a]pyrene metabolism in “Metabolism of xenobiotics by cytochrome P450” in the BPS- or BaP-exposed liver tissues of P. olivaceus. The orange color denotes the gene mapped from the BPS-exposed liver transcriptome to each KEGG pathway. The blue-green color denotes the gene mapped from the BaP-exposed liver transcriptomes to each KEGG pathway. Notably, no gene was solely mapped from the BPS-exposed liver transcriptome to a KEGG pathway. (C) The hepatic EROD activity in the liver tissue of BPS- or BaP-injected olive flounder. Data are presented as the mean ± standard deviation (S.D.). Significant differences from the control value are indicated by an asterisk (*) on the data bar (P < 0.05).
Differentially expressed mRNAs in BPS/control [fold change (log 2) >10].
| Gene symbol | Fold | Up or | KEGG orthology |
|---|---|---|---|
| MFSD2AB | 54.69 | up | lco:104920439 mfsd2a; major facilitator superfamily domain containing 2A |
| VTG1 | 45.45 | up | lco:104931934 VgA; vitellogenin-1-like |
| - | 42.91 | up | unnamed protein product |
| VTG2 | 28.09 | up | lco:104931936 VgB; vitellogenin-2-like |
| GPT2L | 24.62 | up | lco:104929222 alanine aminotransferase 2-like |
| IGFBP1A | 23.65 | up | lco:104929331 insulin-like growth factor-binding protein 1 |
| ZP3 | 23.30 | up | lco:104940476 zona pellucida sperm-binding protein 3 |
| MIOX | 19.20 | up | lco:104918107 miox; myo-inositol oxygenase |
| FAM46BA | 18.23 | up | lco:104938655 fam46b; protein FAM46A |
| IGFBP1A | 17.75 | up | lco:104929331 insulin-like growth factor-binding protein 1 |
| CCER | 15.81 | up | lco:104930694 coiled-coil domain-containing glutamate-rich protein 1-like |
| ALDOB | 14.58 | up | lco:104939510 aldob; fructose-bisphosphate aldolase B |
| AGXTB | 14.11 | up | mze:101480149 serine—pyruvate aminotransferase-like |
| FAM20C | 13.83 | up | mze:101477115 extracellular serine/threonine protein kinase FAM20C-like |
| MUC2 | 13.19 | up | lco:104921854 prg4; proteoglycan 4 |
| UNNAMED | 12.73 | up | lco:109140524 alanine aminotransferase 2-like |
| SI:DKEY-178E17.3 | 12.58 | up | lco:104921667 somatomedin-B and thrombospondin type-1 |
| MOB2 | 11.62 | up | lco:104918109 MOB kinase activator 2 |
| ZP4 | 11.50 | up | lco:104940483 zona pellucida sperm-binding protein 4-like |
| ZGC:112285 | 11.36 | up | mze:101487569 elastase-1-like |
| GDF15 | -99.77 | down | lco:104920968 gdf15; growth differentiation factor 15 |
| OSER1 | -32.97 | down | lco:104938359 oser1; oxidative stress responsive serine rich 1 |
| DIO3 | -24.48 | down | lco:104924692 thyroxine 5-deiodinase-like |
| ANGPTL4 | -22.35 | down | lco:109141011 angiopoietin-related protein 4-like |
| PHGDH | -19.82 | down | lco:104931034 phgdh; phosphoglycerate dehydrogenase |
| TNIP3 | -18.58 | down | lco:104933799 TNFAIP3-interacting protein 1-like |
| PHGDH | -15.40 | down | lco:104931034 phgdh; phosphoglycerate dehydrogenase |
| TNNT1 | -15.27 | down | lco:104939292 troponin T, slow skeletal muscle-like |
| - | -13.82 | down | unnamed protein product |
| HAMP | -11.89 | down | xma:102230476 hamp; hepcidin antimicrobial peptide |
| TGM2L | -11.40 | down | lco:104929140 protein-glutamine gamma-glutamyltransferase 2-like |
| - | -10.38 | down | unnamed protein product |
| CALCOCO1B | -8.92 | down | mze:101469246 calcium-binding and coiled-coil domain-containing protein 1-like |
| KRT18 | -8.53 | down | lco:104930767 keratin, type I cytoskeletal 18-like |
| SERPINH1B | -8.49 | down | ola:100529194 serpinh1; serpin H1 isoform X1 |
| HP | -8.34 | down | mze:101466498 haptoglobin-like |
| GK | -8.13 | down | lco:104922970 gck; glucokinase |
| ISYNA1 | -7.62 | down | lco:104926597 isyna1; inositol-3-phosphate synthase 1-A |
| TCNL | -7.61 | down | lco:104937502 transcobalamin-1 |
| IGFBP3 | -7.55 | down | lco:104927720 igfbp3; insulin like growth factor binding protein 3 |
Differentially expressed mRNAs in BaP/control [fold change (log 2) >10].
| Gene symbol | Fold | Up or | KEGG orthology |
|---|---|---|---|
| CYP1A | 176.14 | up | lco:104920743 CYP1A; cytochrome P450 1A1 |
| UGT1A1 | 60.52 | up | lco:109136658 UDP-glucuronosyltransferase-like |
| IGFBP1A | 42.85 | up | lco:104929331 insulin-like growth factor-binding protein 1 |
| - | 29.24 | up | tng:GSTEN00019789G001 unnamed protein product |
| PDK2B | 29.16 | up | lco:104927162 pyruvate dehydrogenase (acetyl-transferring) kinase isozyme 2, |
| GM46320 | 22.65 | up | mmu:108167963 Gm46320; predicted gene, 46320 |
| MIOX | 21.93 | up | lco:104918107 miox; myo-inositol oxygenase |
| GPT2L | 21.88 | up | lco:104929222 alanine aminotransferase 2-like |
| A4GUE9 | 16.28 | up | lco:109140778 insulin-like growth factor II |
| MOB2 | 16.19 | up | lco:104918109 MOB kinase activator 2 |
| ZGC | 15.50 | up | mze:101487569 elastase-1-like |
| GPT2-LIKE | 13.44 | up | lco:109140524 alanine aminotransferase 2-like |
| TIPARP | 13.28 | up | lco:104924110 tiparp; TCDD inducible poly (ADP-ribose) polymerase |
| WFDC2 | 12.18 | up | lco:104919425 WAP four-disulfide core domain protein 18-like |
| CYP26A1 | 12.14 | up | lco:104928862 cytochrome P450 26A1 |
| - | 12.10 | up | nle:105739288 uncharacterized LOC105739288 |
| SI:DKEY-188C14 | 12.08 | up | lco:104923163 serine/arginine repetitive matrix protein 1-like |
| EEF2B | 11.73 | up | mze:101482186 elongation factor 2 |
| SI:DKEY-188C14 | 11.72 | up | lco:104923163 serine/arginine repetitive matrix protein 1-like |
| AGXTB | 11.63 | up | mze:101480149 serine—pyruvate aminotransferase-like |
| GDF15 | -344.78 | down | lco:104920968 gdf15; growth differentiation factor 15 |
| TNIP3 | -66.63 | down | lco:104933799 TNFAIP3-interacting protein 1-like |
| HSPA5 | -34.02 | down | lco:104925213 hspa5; 78 kDa glucose-regulated protein |
| ANGPTL4 | -32.22 | down | lco:109141011 angiopoietin-related protein 4-like |
| PFKFB3 | -27.26 | down | lco:104933238 pfkfb3; 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 |
| PHGDH | -23.58 | down | lco:104931034 phgdh; phosphoglycerate dehydrogenase |
| OSER1 | -22.25 | down | lco:104938359 oser1; oxidative stress responsive serine rich 1 |
| HSP90B1 | -18.65 | down | mze:101467243 hsp90b1; heat shock protein 90 beta family member 1 |
| CRELD2 | -17.52 | down | lco:104926574 creld2; cysteine rich with EGF like domains 2 |
| MIDN | -17.09 | down | lco:104924845 midnolin-A-like |
| SGK1 | -13.80 | down | lco:104925665 sgk1; serum/glucocorticoid regulated kinase 1 |
| TGM2L | -13.53 | down | lco:104929140 protein-glutamine gamma-glutamyltransferase 2-like |
| IARS | -12.37 | down | lco:104931396 iars; isoleucyl-tRNA synthetase |
| LIPG | -11.84 | down | lco:104922983 lipg; lipase G, endothelial type |
| CALCOCO1B | -11.17 | down | mze:101469246 calcium-binding and coiled-coil domain-containing protein 1-like |
| HAMP | -11.12 | down | xma:102230476 hamp; hepcidin antimicrobial peptide |
| DNAJB11 | -10.99 | down | mze:101474382 dnajb11; DnaJ heat shock protein family (Hsp40) member B11 |
| YARS | -10.93 | down | lco:104920437 yars; tyrosyl-tRNA synthetase |
| KRT18 | -9.80 | down | lco:104930767 keratin, type I cytoskeletal 18-like |
| CALR3B | -9.53 | down | lco:104931427 calreticulin-like |
Fig 4Hierarchical clustering analysis of differentially expressed genes and biochemical evidences.
(A) Transcriptional profiles of estrogen receptor genes (i.e. erα, erβ, and erγ) in the BPS- or BaP-exposed liver tissues of P. olivaceus; (B) the effect of BPS and BaP injections on the plasma 17β-estradiol (E2) concentration in the liver tissues of P. olivaceus. E2 concentration is expressed as pg/mL. Each value is an average of five biological replicates, and data are shown as means ± S.D; (C) the effect of BPS and BaP injections on the plasma vitellogenin (VTG) concentration in the liver tissues of P. olivaceus. VTG concentration is expressed as μg/mL. Each value is an average of five biological replicates, and data are shown as means ± S.D; (D) transcriptional expressions of genes associated with the innate immunity in the BPS- or BaP-exposed liver tissues of P. olivaceus. (E) the effect of BPS and BaP injections on the plasma complement activity in the liver tissues of P. olivaceus. The activity is expressed as U/mL. Each value is an average of five biological replicates, and data are shown as means ± S.D. The asterisk symbol (*) indicates statistical significance (P < 0.05) compared to the control values.
Fig 5Enzymatic activities of biotransformation and antioxidant defense systems.
The effect of the BPS and BaP injections on the enzymatic activities of the (A) GST, (B) CAT, and (C) SOD proteins in the liver tissues of P. olivaceus at 6 h. The activity is expressed as μmol /min/mL. Each value is an average of five biological replicates, and data are shown as means ± S.D. The asterisk symbol (*) indicates statistical significance (P < 0.05) compared to the control values.
Fig 6qPCR validation results on the mRNA expressions of 15 randomly selected genes.
(A) The mRNA expressions of 15 genes were selected from the RNA-seq data (P < 0.05). (B) Validation of the mRNA expression patterns of the selected 15 genes by qPCR. Abbreviations of the gene names are as follows: Major facilitator superfamily domain contating 2A, mfsd2a; Vitellogenin 1, vtg1; Zona pellucida sperm-binding protein 3, zp3; Zona pellucida sperm-binding protein 4, zp4; Estrogen receptor alpha, erα; Cytochrome P450 1A1, cyp1a1; Glutathione S-transferase zeta 1, gstz; Catalase, cat; Hepcidin antimicrobial peptide, hamp; Calreticulin 3, calr3; Complement C9, c9; Complement H, ch; Calnexin, cnx; lectin; Selenoprotein F, selenof.
Fig 7Schematic summary of unique and common transcriptional responses in the BPS- and BaP-exposed liver tissues of P. olivaceus.
Red arrow means increased transcriptional metabolism and green arrow represents decreased transcriptional metabolism.